LLY - What's Going On With Eli Lilly And Company Shares Thursday? | Benzinga
Eli Lilly and Company (NYSE:LLY) stock is moving lower on Thursday on possible continued weakness after recent weight loss data from Roche.
What To Know: On Wednesday, Roche announced positive Phase I data from its clinical trial in regards to CT-996, a once-daily oral pharmaceutical being developed for the treatment of both type 2 diabetes and obesity.
The data showed a clinically meaningful weight loss of -7.3% and placebo adjusted weight loss of -6.1% following four weeks of treatment. The trial contained participants with obesity but not ...